1. Home
  2. BCAX vs TILE Comparison

BCAX vs TILE Comparison

Compare BCAX & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • TILE
  • Stock Information
  • Founded
  • BCAX 2018
  • TILE 1973
  • Country
  • BCAX United States
  • TILE United States
  • Employees
  • BCAX N/A
  • TILE N/A
  • Industry
  • BCAX
  • TILE Home Furnishings
  • Sector
  • BCAX
  • TILE Consumer Discretionary
  • Exchange
  • BCAX NYSE
  • TILE Nasdaq
  • Market Cap
  • BCAX 1.3B
  • TILE 1.4B
  • IPO Year
  • BCAX 2024
  • TILE N/A
  • Fundamental
  • Price
  • BCAX $20.17
  • TILE $24.99
  • Analyst Decision
  • BCAX Strong Buy
  • TILE Buy
  • Analyst Count
  • BCAX 4
  • TILE 2
  • Target Price
  • BCAX $41.00
  • TILE $20.00
  • AVG Volume (30 Days)
  • BCAX 274.3K
  • TILE 575.6K
  • Earning Date
  • BCAX 11-12-2024
  • TILE 11-01-2024
  • Dividend Yield
  • BCAX N/A
  • TILE 0.16%
  • EPS Growth
  • BCAX N/A
  • TILE 11277.07
  • EPS
  • BCAX N/A
  • TILE 1.44
  • Revenue
  • BCAX N/A
  • TILE $1,305,766,000.00
  • Revenue This Year
  • BCAX N/A
  • TILE $6.54
  • Revenue Next Year
  • BCAX N/A
  • TILE $3.87
  • P/E Ratio
  • BCAX N/A
  • TILE $17.37
  • Revenue Growth
  • BCAX N/A
  • TILE 2.66
  • 52 Week Low
  • BCAX $18.33
  • TILE $9.87
  • 52 Week High
  • BCAX $28.09
  • TILE $26.11
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • TILE 72.19
  • Support Level
  • BCAX N/A
  • TILE $24.91
  • Resistance Level
  • BCAX N/A
  • TILE $24.97
  • Average True Range (ATR)
  • BCAX 0.00
  • TILE 0.89
  • MACD
  • BCAX 0.00
  • TILE 0.33
  • Stochastic Oscillator
  • BCAX 0.00
  • TILE 87.10

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments - AMS and EAAA.

Share on Social Networks: